ArticleTherapeutic advances in medical oncology2025

Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study.

Yizhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.